Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Emergent Biosolutions (EBS)

Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 360,526
  • Shares Outstanding, K 52,402
  • Annual Sales, $ 1,049 M
  • Annual Income, $ -760,500 K
  • 60-Month Beta 1.60
  • Price/Sales 0.37
  • Price/Cash Flow 8.95
  • Price/Book 1.08
Trade EBS with:

Options Overview Details

View History
  • Implied Volatility 95.18% ( -2.79%)
  • Historical Volatility 236.45%
  • IV Percentile 7%
  • IV Rank 12.97%
  • IV High 505.77% on 02/07/24
  • IV Low 34.00% on 10/11/23
  • Put/Call Vol Ratio 0.64
  • Today's Volume 1,794
  • Volume Avg (30-Day) 3,306
  • Put/Call OI Ratio 0.43
  • Today's Open Interest 51,599
  • Open Int (30-Day) 45,792

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.32
  • Number of Estimates 1
  • High Estimate 0.32
  • Low Estimate 0.32
  • Prior Year -1.44
  • Growth Rate Est. (year over year) +122.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.75 +2.22%
on 09/18/24
13.28 -48.02%
on 08/19/24
-3.84 (-35.75%)
since 08/16/24
3-Month
5.25 +31.43%
on 08/07/24
15.10 -54.30%
on 07/30/24
+0.84 (+13.86%)
since 06/18/24
52-Week
1.42 +385.92%
on 02/06/24
15.10 -54.30%
on 07/30/24
+3.19 (+85.98%)
since 09/18/23

Most Recent Stories

More News
Why Emergent BioSolutions Stock Is Skyrocketing Today

Concerns about the mpox outbreak are causing Emergent BioSolutions' shares to jump.

EBS : 6.90 (+0.29%)
Emergent BioSolutions (EBS) Q2 2024 Earnings Call Transcript

EBS earnings call for the period ending June 30, 2024.

EBS : 6.90 (+0.29%)
Emergent Biosolutions: Q2 Earnings Snapshot

Emergent Biosolutions: Q2 Earnings Snapshot

EBS : 6.90 (+0.29%)
Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript

EBS earnings call for the period ending March 31, 2024.

EBS : 6.90 (+0.29%)
Emergent Biosolutions: Q1 Earnings Snapshot

Emergent Biosolutions: Q1 Earnings Snapshot

EBS : 6.90 (+0.29%)
Emergent BioSolutions (EBS) Q4 2023 Earnings Call Transcript

EBS earnings call for the period ending December 31, 2023.

EBS : 6.90 (+0.29%)
Emergent Biosolutions: Q4 Earnings Snapshot

Emergent Biosolutions: Q4 Earnings Snapshot

EBS : 6.90 (+0.29%)
Emergent Biosolutions: Q3 Earnings Snapshot

Emergent Biosolutions: Q3 Earnings Snapshot

EBS : 6.90 (+0.29%)
Emergent BioSolutions (EBS) Q3 2023 Earnings Call Transcript

EBS earnings call for the period ending September 30, 2023.

EBS : 6.90 (+0.29%)
Emergent BioSolutions Partners with Emmitt Smith to Launch Ready to Rescue Campaign to Help Save Lives Amidst Rising Opioid Epidemic

/PRNewswire/ -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced it is teaming up with football icon, Emmitt Smith, to break down the stigma around...

EBS : 6.90 (+0.29%)

Business Summary

Emergent BioSolutions, Inc. is a global specialty biopharmaceutical company offering specialized products to health care providers and governments to combat emerging public health threats. It also supplies vaccines to domestic and international non-government organizations and governments in/ outside...

See More

Key Turning Points

3rd Resistance Point 7.88
2nd Resistance Point 7.63
1st Resistance Point 7.26
Last Price 6.90
1st Support Level 6.64
2nd Support Level 6.39
3rd Support Level 6.02

See More

52-Week High 15.10
Fibonacci 61.8% 9.87
Fibonacci 50% 8.26
Last Price 6.90
Fibonacci 38.2% 6.65
52-Week Low 1.42

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar